Role of regulatory T cell glucocorticoid-induced leucine zipper (GILZ) in the chronically inflamed intestine

调节性 T 细胞糖皮质激素诱导的亮氨酸拉链 (GILZ) 在慢性炎症肠道中的作用

基本信息

  • 批准号:
    10215504
  • 负责人:
  • 金额:
    $ 12.08万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-07-13 至 2023-04-30
  • 项目状态:
    已结题

项目摘要

Project Summary/Abstract Glucocorticoid-induced leucine zipper (GILZ) is a broadly-expressed transcription factor whose expression is induced via endogenous or synthetic glucocorticoid (GC) signaling through the glucocorticoid receptor (GR). GILZ is thought to meditate many of GCs’ anti-inflammatory effects in T lymphocytes, such as induction of TGFβ signaling and inhibition of NFκB, MAPK, and AP-1 pathways. Conditional deletion of GILZ in CD4+ T cells leads to enhancement of experimental dinitrobenzene sulfonic acid (DNBS)-induced colitis, a Th1-mediated form of experimental inflammatory bowel disease (IBD). Steroid hormones, including corticosteroids and sex steroid hormones such as 17β-estradiol (estrogen, E2), demonstrate considerable promiscuity in receptor binding. E2 has been shown to antagonize GILZ in human uterine epithelial cells, but little is known regarding the mechanism(s) by which it may contribute to GILZ expression and/or function in T cells. Our preliminary data reveal a robust induction of GILZ at the mRNA and protein levels in regulatory T cells (Tregs) isolated from Crohn’s disease (CD) patients and SAMP/YitFC (“SAMP”) mice, a spontaneous model of Crohn’s-like disease. GILZ upregulation (“GILZhigh”) in these Tregs was associated with a relative decrease in estrogen receptor beta (ERβ) expression, suggesting that GILZ expression in Tregs may be responsive to estrogen signaling. Furthermore, GILZhigh Tregs exhibited reduced suppressive function compared to their GILZlow counterparts, suggesting that optimal GILZ-mediated immunosuppression in Tregs may require intact ERβ signaling. Several chronic inflammatory and autoimmune diseases exhibit reductions in ERβ expression and/or activity, leading to the intriguing possibility that diminished ERβ expression contributes to inflammation via disruption of normally-protective Treg GILZ-mediated mechanisms. Our hypothesis is that the protective functions of Treg- specific GILZ require intact ERβ signaling, and therefore fail to mediated sufficient immunoprotection in ERβ-depleted environments, such as the IBD intestine. The goal of this project is to determine the mechanism(s) by which reduced ERβ-specific signaling influences the expression and function of GILZ in IBD- associated Tregs. We will make use of novel tools (GILZ transgenic and knockout mice and MaxCyte lentiviral transfection of primary human and murine T cells) to manipulate GILZ expression in ERβ-deficient versus – sufficient Tregs in order to understand how intact ERβ signaling influences the expression (Subaim 1a) and function (Subaim 1b) of Treg-specific GILZ. Leveraging a large cohort of CD patients available through the Cleveland Digestive Disease Research Core Center (DDRCC), we will apply single-cell RNA sequencing to CD patient mucosal Tregs (discarded surgical samples) in order to identify unique transcriptional signatures (Subaim 1c) associated with ERβlow/GILZhigh Tregs. These assays will provide critical data to inform future proposals focused on the intersection of E2 signaling and GILZ activity in Tregs. Successful completion of this proposal will provide mechanistic insight into the regulation of Treg GILZ expression and function via estrogen signaling. These studies will determine the link between diminished ERβ signaling, characteristic of many auto- inflammatory diseases including IBD, and glucocorticoid signaling, with an ultimate goal of developing improved personalized medicine approaches for CD patients.
项目摘要/摘要 糖皮质激素诱导的亮氨酸拉链(GILZ)是一种宽阔表达的转录因子,其表达为 通过内源性或合成糖皮质激素(GC)信号通过糖皮质激素受体(GR)诱导。 吉尔兹被认为会冥想在T淋巴细胞中的许多GCS的抗炎作用,例如诱导TGFβ NFκB,MAPK和AP-1途径的信号传导和抑制。 CD4+ T细胞中GILZ的条件缺失导致 增强实验性二硝基苯磺酸(DNB)诱导的结肠炎,一种Th1介导的形式的 实验性炎症性肠病(IBD)。类固醇激素,包括皮质类固醇和性类固醇 诸如17β-雌激素(雌激素,E2)之类的术语表现出受体结合的考虑杂交。 E2 已经显示出在人子宫上皮细胞中与吉尔兹拮抗的 它可能有助于T细胞中吉尔兹表达和/或功能的机制。我们的初步数据 揭示了从从mRNA和蛋白质水平上的gilz诱导的调节性T细胞(Treg)中的蛋白质水平 克罗恩病(CD)患者和SAMP/YITFC(“ SAMP”)小鼠,这是克罗恩病的赞助模型。 这些Treg中的Gilz上调(“ Gilzhigh”)与雌激素受体β的相对降低有关 (ERβ)表达,表明treg中的吉尔兹表达可能对雌激素信号反应。 此外,与吉尔兹洛(Gilzlow)相比 提示Treg中最佳的GILZ介导的免疫抑制可能需要完整的ERβ信号传导。 ERβ表达和/或活性的几种慢性炎症和自身免疫性疾病的降低, 导致ERβ表达降低的引人入胜的可能性会导致炎症 通常具有保护的Treg Gilz介导的机制。我们的假设是Treg-的受保护功能 特定的吉尔兹需要完整的ERβ信号传导,因此无法介导足够的免疫保护 ERβ缺乏的环境,例如IBD肠。该项目的目的是确定 降低ERβ特异性信号传导的机制会影响GILZ在IBD-的表达和功能 相关的treg。我们将利用新颖的工具(吉尔兹转基因和淘汰小鼠和maxcyte慢病毒 转染原代人和鼠T细胞)以操纵ERβ缺陷与 - 足够的Treg,以了解完整的ERβ信号如何影响表达(Subaim 1a)和 Treg特异性吉尔兹的功能(Subaim 1b)。利用大量通过 克利夫兰消化疾病研究核心中心(DDRCC),我们将对CD应用单细胞RNA测序 患者粘膜treg(丢弃的手术样本),以识别独特的转录特征 (subaim 1c)与erβlow/gilzhigh treg相关联。这些评估将提供关键数据以告知未来 提案集中在Treg中E2信号传导和GILZ活性的相交。成功完成 提案将通过雌激素对Treg Gilz表达和功能的调节提供机械洞察力 信号。这些研究将确定ERβ信号下降之间的联系,这是许多自动的特征 包括IBD和糖皮质激素信号在内的炎症性疾病,其最终目标是发展 CD患者的个性化医学方法。

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sam68 contributes to intestinal inflammation in experimental and human colitis.
  • DOI:
    10.1007/s00018-021-03976-7
  • 发表时间:
    2021-12
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Goodman WA;Basavarajappa SC;Liu AR;Rodriguez FDS;Mathes T;Ramakrishnan P
  • 通讯作者:
    Ramakrishnan P
Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease.
Impact of COVID-19 on Patients with Inflammatory Bowel Disease.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Wendy Ann Goodman其他文献

Wendy Ann Goodman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Wendy Ann Goodman', 18)}}的其他基金

Estrogen-mediated immune regulation in human and experimental inflammatory bowel disease
人类和实验性炎症性肠病中雌激素介导的免疫调节
  • 批准号:
    10853530
  • 财政年份:
    2023
  • 资助金额:
    $ 12.08万
  • 项目类别:
Estrogen-mediated immune regulation in human and experimental inflammatory bowel disease
人类和实验性炎症性肠病中雌激素介导的免疫调节
  • 批准号:
    10574487
  • 财政年份:
    2021
  • 资助金额:
    $ 12.08万
  • 项目类别:
Estrogen-mediated immune regulation in human and experimental inflammatory bowel disease
人类和实验性炎症性肠病中雌激素介导的免疫调节
  • 批准号:
    10182035
  • 财政年份:
    2021
  • 资助金额:
    $ 12.08万
  • 项目类别:
Estrogen-mediated immune regulation in human and experimental inflammatory bowel disease
人类和实验性炎症性肠病中雌激素介导的免疫调节
  • 批准号:
    10355534
  • 财政年份:
    2021
  • 资助金额:
    $ 12.08万
  • 项目类别:
Role of regulatory T cell glucocorticoid-induced leucine zipper (GILZ) in the chronically inflamed intestine
调节性 T 细胞糖皮质激素诱导的亮氨酸拉链 (GILZ) 在慢性炎症肠道中的作用
  • 批准号:
    10057684
  • 财政年份:
    2020
  • 资助金额:
    $ 12.08万
  • 项目类别:
Molecular mechanisms contributing to gender differences in regulatory T cell function in Crohn's disease and experimental IBD
克罗恩病和实验性 IBD 调节性 T 细胞功能性别差异的分子机制
  • 批准号:
    9750684
  • 财政年份:
    2015
  • 资助金额:
    $ 12.08万
  • 项目类别:
Molecular mechanisms contributing to gender differences in regulatory T cell function in Crohn's disease and experimental IBD
克罗恩病和实验性 IBD 调节性 T 细胞功能性别差异的分子机制
  • 批准号:
    9146962
  • 财政年份:
    2015
  • 资助金额:
    $ 12.08万
  • 项目类别:
KLF2 as a Regulator of Metabolic Inflammation
KLF2 作为代谢炎症的调节剂
  • 批准号:
    8254121
  • 财政年份:
    2012
  • 资助金额:
    $ 12.08万
  • 项目类别:

相似国自然基金

无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
  • 批准号:
    62372118
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
CHCHD2在年龄相关肝脏胆固醇代谢紊乱中的作用及机制
  • 批准号:
    82300679
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
颗粒细胞棕榈酰化蛋白FXR1靶向CX43mRNA在年龄相关卵母细胞质量下降中的机制研究
  • 批准号:
    82301784
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
  • 批准号:
    82301217
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
  • 批准号:
    82373667
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目

相似海外基金

Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis
IL-6反式信号传导在动脉粥样硬化发展和晚期发病机制中的作用
  • 批准号:
    10652788
  • 财政年份:
    2023
  • 资助金额:
    $ 12.08万
  • 项目类别:
Co-Delivery Dose-Controllable Implants for Advanced Chronic Eye Disease Treatment
用于治疗晚期慢性眼病的共同给药剂量可控植入物
  • 批准号:
    10647078
  • 财政年份:
    2023
  • 资助金额:
    $ 12.08万
  • 项目类别:
PRISM
棱镜
  • 批准号:
    10749441
  • 财政年份:
    2023
  • 资助金额:
    $ 12.08万
  • 项目类别:
Clinical Trial Readiness for Monitoring Muscle Inflammation in Duchenne Muscular Dystrophy
监测杜氏肌营养不良症肌肉炎症的临床试验准备
  • 批准号:
    10725465
  • 财政年份:
    2023
  • 资助金额:
    $ 12.08万
  • 项目类别:
A novel approach for prevention of Bronchopulmonary dysplasia in at-risk pre-term infants
预防高危早产儿支气管肺发育不良的新方法
  • 批准号:
    10765750
  • 财政年份:
    2023
  • 资助金额:
    $ 12.08万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了